戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1  0.08 times at low filtration rates (4 g l-1 infusates).
2  the primate right frontal lobe or pons with infusate.
3  (50 microM) was added to the 100 mM glucose infusate.
4 ance to visualize the anatomic spread of the infusate and calculate coverage.
5 ed CED facilitates extensive distribution of infusate and specific targeting of tumor cells.
6 f HA2000 increased substantially relative to infusate and the subsynovial and lymph concentrations fe
7  sources (skin, catheter segments, hubs, and infusate) and confirmed by restriction-fragment DNA subt
8 es at intermediate filtration rates (2 g l-1 infusates) and 1.26 +/- 0.08 times at low filtration rat
9 s were performed using Evans blue dye as the infusate, and interstitial fluid pressure was measured.
10 priate, regardless of treatment intensity or infusate characteristics.
11 ml(-1) (mean +/-s.e.m., n= 31), exceeded the infusate concentration, 0.20 mg ml(-1), while subsynovia
12 rolysis rates measured over a broad range of infusate concentrations.
13  that observed in lesioned animals receiving infusate controls.
14 aging tracer (gadoteridol) was used to track infusate distribution during real-time intraoperative ma
15 esponses, along with luminal distribution of infusate during esophageal rapid and slow infusion of ai
16 inemic clamp using [1-(13)C]glucose-enriched infusate followed by nonenriched glucose.
17 use of the inability to accurately visualize infusates in real-time and lack of targeting modalities
18 entral hippocampus as early as 2 weeks after infusate introduction.
19 04 times at high filtration rates (0.2 g l-1 infusates; mean +/- S.E.M.), 1.60 +/- 0.09 times at inte
20 in the aspirate was greater than that in the infusate (P = 0.0001, Student's paired t test).
21 m(2)/wk was precluded by the total volume of infusate required, 2.5 to 3.0 L.
22                                    Since the infusate's osmotic pressure was only 0.9 cmH2O, this imp
23 l, non-adhesive NP via CED in a hyperosmolar infusate solution.
24 , and proper preparation of local anesthetic infusate solutions are all considered essential componen
25 placebo infusion of the same volume and same infusate temperature.
26 erum sodium concentration over 200 min or an infusate that maintained serum sodium concentration.
27 ced delivery (CED) provides direct access of infusates to brain tumors; however, clinical translation
28 ugh further dose escalation was precluded by infusate volume constraints, this SU101 dose schedule re
29 sertion (infusion of peripherally compatible infusates vs. vesicants), and duration of use (</=5 days
30            Whereas the C5-to-C3 ratio of the infusate was 1.07, the ratio in UDP-glucose was <1.0 in
31                            The next day, the infusate was changed to a lipid emulsion that contained
32                                              Infusates were perfused through forearm skin using micro
33 ion of platelet-like particles (PLPs) in the infusate, which include platelets released during ex viv